Trends in the incidence of use of non ‐insulin glucose‐lowering drugs between 2006 and 2013 in France
In conclusion, after reaching a peak in 2010, the incidence of use of NIGLDs has markedly decreased in France. Since then, prescribers seem to have reverted to older and well‐known therapies.
This article is protected by copyright. All rights reserved.
Source: Fundamental and Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Mickael Arnaud, Julien Bezin, Bernard B égaud, Antoine Pariente, Francesco Salvo Tags: Original Article Source Type: research
More News: Databases & Libraries | Drugs & Pharmacology | Fortamet | Insulin | Insurance | Metformin | Study